Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04623372
Other study ID # CHM-2020/S11/02
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date February 3, 2021
Est. completion date November 2022

Study information

Verified date March 2022
Source Centre Hospitalier le Mans
Contact Christelle JADEAU
Phone 02 44 71 07 81
Email cjadeau@ch-lemans.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The skin punch-biopsies are frequently used technical acts in the current medical practice. However, while these skills are actually easy to perform, the subsequent healing procedure remains still poorly harmonized. Indeed, it usually depends on the physicians personal experiences and some preconceived considerations without any reliable scientific background. This study aims to explore the performances of a directed wound healing behaviour in comparison with the suture.


Description:

Because of the lack of reliable scientific data about this topic, the usual behaviours concerning the subsequent healing procedure after a punch skin biopsy remains still poorly defined and harmonized, currently based on the physicians personal experiences and some preconceived considerations. The few studies available in the literature are supporting the assumption that the use of a directed wound healing could be as effective as the widely-used procedure of performing a suture while it does not downgrade the quality of care. However, due to their methodological quality and applicability, they have not led to a substantial modification of the common behaviours. Moreover, the development of some new and the improvement of the former resources could have changed the situation. Therefore, this study aims to bring some recent pragmatic data to assist the implementation of recommendations regarding the attitude to adopt for the healing procedure after a skin punch-biopsy. The protocol will consist in a monocentric, prospective, randomized and controlled, interventional study. It will be carried out with two parallel groups, in a non-inferiority setting. All the included participants will undergo a skin biopsy using a punch of 4 mm diameter. Then they will either get a suture by separated knots using a non-absorbable 4.0 wire and a dry dressing, either get only a dry dressing. All the subjects will receive a phone call at five days after the skin biopsy in order to collect the self-evaluation of the maximal experienced pain during the healing period. They will also have a single follow-up appointment one month after the inclusion and a photograph of the scar will be taken during this medical consultation. This picture will be evaluated by a blind independent investigator without the presence of the patient.


Recruitment information / eligibility

Status Recruiting
Enrollment 400
Est. completion date November 2022
Est. primary completion date November 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - adult person (age greater than or equal to 18 years) - either hospitalized patient in a conventional or in a day care department, either seen at a medical appointment in Le Mans General Hospital - person on whom the indication of one or several skin biopsy(ies) using a punch of 4 mm diameter has been established - affiliated or beneficiary of a statutory social insurance scheme - free and informed written consent, signed by both the participant and the investigator (the day of inclusion at the latest and prior to any examination needed by the protocol) after an oral and written information Exclusion Criteria: - skin biopsy on the face or the cervical area - pregnant, breastfeeding or parturient woman - person deprived of liberty by an administrative act or a court decision - patient requiring compulsory mental health care - minor or legally protected adult - patient that is no longer in a condition to express his or her wishes - person that have participated or that are taking part in an interventional study over the past 30 days (condition of exclusivity)

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
suture
suture by separated knots using a non-absorbable 4.0 wire and application of a dry dressing after the punch skin-biopsy
directed wound healing
application of a dry dressing without any prior suture after the skin biopsy.

Locations

Country Name City State
France Centre Hospitalier Du Mans Le Mans

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier le Mans

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Assess aesthetic quality of the scar by physician the asserted aesthetic quality of the scar will be assessed by a dermatologist with 4-level scale one month after skin punch biopsy
Secondary Assess aesthetic quality of the scar by patient The asserted aesthetic quality of the scar will be assessed by the participant himself using a 4-level scale 1 month after skin biopsy punch
Secondary Assess maximal pain experienced by the patient The maximal pain experienced by the patient during the Healing phase will be assessed with a numerical scale ranging from 0 to 10 1 month after skin biopsy punch
Secondary Assess amount of bleeding the scoring of the amount of bleeding subsequent to the skin biopsy will be assessed with a numerical scale ranging from 0 to 10 immediately after skin biopsy punch
Secondary Assess clotting time The clotting time subsequent to the skin biopsy will be assessed using a 4-level scale immediately after skin biopsy punch
Secondary Observe cutaneous infection occurrence of a cutaneous infection that had required an antibiotic treatment and/or the achievement of a drainage during the month following the skin punch-biopsy 1 month after skin biopsy punch